Dr. Yuichi Shimada, MD, MPH, is Research Director of the Hypertrophic Cardiomyopathy Center and Associate Professor of Medicine at Columbia University Irving Medical Center. He is also a Faculty of the Frontiers in Cardiovascular Discovery Workshop as a part of the Body in Health and Disease Course at Columbia University Vagelos College of Physicians and Surgeons.

Dr. Shimada received MD degree from The University of Tokyo in 2007. He was selected as one of the 2 exchange medical students who were allowed to experience a three-month sub-internship at Johns Hopkins Hospital, where he decided to pursue his career as a physician-scientist in the United States. After graduation, he served as a house staff at the University of Tokyo Hospital (2007-2008).

Dr. Shimada completed Internal Medicine residency at Beth Israel Medical Center (2008-2011) and was selected as Chief Medical Resident (2011-2012). He moved on to cardiology fellowship at Brigham & Women's Hospital, Harvard Medical School (2012-2015). He also honed his clinical research skills at TIMI Study Group and Harvard Clinical Research Institute during the fellowship. He spent the last year of his cardiology fellowship as the first "hypertrophic cardiomyopathy fellow" at Massachusetts General Hospital, Harvard Medical School (2014-2015). Concurrently with his residency and fellowship, he enrolled in the Master of Public Health Program at Johns Hopkins (2011-2014) and was inducted into the Delta Omega Alpha Public Health Honor Society at Hopkins.

After graduating from his fellowship in 2015, Dr. Shimada served as an attending cardiologist of the Hypertrophic Cardiomyopathy Program at Massachusetts General Hospital (2015-2017). He joined the faculty of the Division of Cardiology at Columbia University Irving Medical Center in 2017.

Dr. Shimada has served as an ad-hoc reviewer/judge for research grant funding systems of American Heart Association (5 times), University of Muenster (Germany), and Swiss National Science Foundation (twice). He is an editorial board member of 3 peer-reviewed scientific journals. He has performed peer-review as an ad-hoc reviewer for >40 scientific journals, and the list includes top journals such as Circulation, European Heart Journal, Journal of the American College of Cardiology, JAMA Cardiology, and Annals of Internal Medicine. He has also received multiple awards and prizes for his research and gave >100 invited lectures nationally and internationally (e.g., Portugal, Korea, and Japan). Dr. Shimada has been a site investigator and site principal investigator of several multi-center, international, randomized controlled trials on hypertrophic cardiomyopathy and heart failure. Additionally, Dr. Shimada serves as a Board Member and Chair of Scholarship Committee at Japanese Medical Society of America.